The prognostic value of estrogen receptor immunocytochemistry (ERICA) in breast cancer does not depend on the immunostaining intensity

Breast Disease

Volumn 9, Issue 3, 1996, Pages 157-170

  Younes, Mamoun ^a,b   Laucirica, Rodolfo ^a   Miller, Charles C ^b   Brown, Richard W ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Estrogen receptor; Immunohistochemistry; Prognosis; Survival

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029777495     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Blarney RW, Bishop HM, Blake JR, et al: Relationship between primary breast tumor receptor status and patient survival. Cancer 1980;46:2765-2769.
2. Chevallier B, Heintzmann F, Mosseri V, et al: Prognostic value of estrogen and progesterone receptors in operable breast cancer. Cancer 1988;62:2517-2524.
3. Molino A, Turazza M, Bonetti A, et al: Estrogen and progesterone receptors in breast cancer: Correlation with clinical and pathological features and with prognosis. Oncology 1992;49:82-88.
4. Lippman ME, Allegra JC: Quantitative estrogen receptor analyses. The response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval. Cancer 1980;46:2829-2834.
5. McGuire WL: Hormone receptors. Their role in predicting prognosis and response to endocrine therapy. Semin Oncol 1978;5:428-433.
6. Wittliff JL: Steroid-hormone receptors in breast cancer. Cancer 1984;53:630-643.
7. Miller BA, Feuer EJ, Hankey BF: Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 1993;43:27-41.
8. Mercer WD, Lippan ME, Wahl TM, et al: The use of immunocytochemical techniques for the detection of steroid hormones in breast cancer cells. Cancer 1980;46:2859-2868.
9. McCarty KS, Woodard BH, Nichols DE, et al: Comparison of biochemical and histochemical techniques for estrogen receptor analyses in mammary carcinoma. Cancer 1980;46:2842-2845.
10. Pertschuk LP, Eisenberg KB, Carter AC, et al: Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies: correlation with biochemistry and clinical endocrine response. Cancer 1985;55:1513-1518.
11. Hendricks JB, Wilkinson EJ: Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors. Modern Pathol 1993;6:765-770.
12. Miller RT, Hapke MR, Greene GL: Immunocytochemical assay for estrogen receptor with monoclonal antibody D753Pγ in routinely processed formaldehyde-fixed breast tissue; comparison with frozen section assay and with monoclonal antibody H222. Cancer 1993;71:3541-3546.
13. Rondez R, Yoshizaki C, Pirozynski W: Determination of nuclear DNA content and hormone receptors in breast cancer by the CAS, 100 cell analysis system as related to morphologic grade and biochemical results. Anal Quant Cytol 1991;13:233-245.
14. Esteban JS, Battifora H, Warsi Z, et al: Quantification of estrogen receptors on paraffin-embedded tumors by image analysis. Mod Pathol 1991;4:53-57.
15. Bacus S, Flowers JL, Press MF, et al: The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol 1988;90: 233-239.
16. Andersen J, Thorpe SM, Rose C, et al: Estrogen receptor in primary breast cancer estimated in paraffin-embedded tissue; a study of its usefulness compared to dextrancoated charcoal assay. Acta Oncologica 1991;30:685-690.
17. Hanna W, McReady DR, Champan JW, et al: The predictive value of ERICA in breast cancer recurrence; a univariate and multivariate analysis. Mod Pathol 1993;6:748-754.
18. Kinsel LB, Szabo E, Greene GL, et al: Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Res 1989;49:1052-1056.
19. Walker KJ, Bouzubar N, Robertson J, et al: Immunocytochemical localization of estrogen receptor in human breast tissue. Cancer Res 1988;48:6517-6522.
20. Battifora H, Esteban JM, Bacus S, et al: Quantitative immunocytochemistry on paraffin-embedded tissues. The Quickgel method. Mod Pathol 1990;3:8A. (Abstract).
21. Bloom HJ, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 1956;11:359-377.
22. Scarff RW, Torloni H: Histological typing of breast tumors. Geneve: WHO; 1968: 13-20.
23. McCarty KS Jr, Barton TK, Fetter BF, et al: Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial carcinoma. Am J Pathol 1979; 96:171-183.
24. Steele GD, Winchester DP, Menck HR, et al: Clinical highlights from the national cancer data base: 1993. CA Cancer J Clin 1993;43:71-82.
25. Boring CC, Squires TS, Tong T: Cancer statistics, 1993. CA Cancer J Clin 1993; 43:7-26.
26. Gasparini G, Pozza F, Harris AL: Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. JNCI 1993; 85:1206-1219.
27. Tsangaris TN, Knox SM, Cheek JH: Tumor hormone receptor status and recurrences in premenopausal patients with node-negative breast carcinoma. Cancer 1992;69: 984-987.
28. Petersen OW, Høyer PE, van Deurs B: Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res 1987;47:5748-5751.
29. Jacquemier JD, Hassoun J, Torrente M, et al: Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages: immunohistochemical study of 107 cases. Breast Cancer Res Treat 1990;15:109-117.
30. Battersby S, Robertson BJ, Anderson TJ, et al: Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. Br J Cancer 1992;65:601-607.
31. Williams G, Anderson E, Howell A, et al: Oral contraceptives (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 1991;48:206-210.
32. O'Keane JC, Okon E, Moroz K, et al: Anti-estradiol immunoperoxidase labeling of nuclei, not cytoplasm, in paraffin sections, determines estrogen receptor status of breast cancer. Am J Surg Pathol 1990;14:121-127.
33. Anderson J, Poulsen H: Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer. Cancer 1989;64:1901-1908.
34. Leong AS-Y, Milios J: Comparison of antibodies to estrogen and progesterone receptors and the influence of microwave-antigen retrieval. Appl Immunohistochem 1993; 1:282-288.
35. King WJ, DeSombre ER, Jensen EV, et al: Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res 1985;45:293-304.